Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Pharma
Autolus enters CAR-T race with FDA approval for Aucatzyl
Autolus is ready to hit the ground running with an FDA nod for its CD19 CAR-T Aucatzyl, a competitor to Gilead's Tecartus and Novartis' Kymriah.
Zoey Becker
Nov 11, 2024 11:30am
Gilead's CAR-T sales stagnate as Trodelvy takes another write-off
Nov 7, 2024 11:16am
BMS, 2seventy scrap Abecma trial in first-line multiple myeloma
Sep 25, 2024 10:52am
Legend strikes cell therapy automation pact with Multiply Labs
Sep 24, 2024 9:00am
Cytiva rolls out new CAR-T manufacturing platform
May 30, 2024 9:19am
ASCO: BMS' triplet, Iovance's Amtagvi-Keytruda target melanoma
May 23, 2024 5:00pm
